Patrick Soon-Shiong
Pharmaceuticals · Los Angeles, California
Net worth
$9.3B
Today
−$69M−0.74%Past month
−$2.2B−19.17%As of Nov 11, 2026, 1:50 PM EST
Medical doctor Patrick Soon-Shiong invented the cancer drug Abraxane. It became a blockbuster thanks to its efficacy against pancreatic cancer. He sold his drug companies Abraxis in 2010 and American Pharmaceutical Partners in 2008 for a combined $9.1 billion. He took his cancer drug maker NantKwest public in 2015 and his biotech startup NantHealth public in 2016. He owns NantWorks, a network of health startups, and has stakes in media firm Tribune Publishing and the Los Angeles Lakers. He bought the Los Angeles Times and San Diego Tribune for $500 million in June 2018. In May 2020, Soon-Shiong's ImmunityBio was selected for the federal government's "Operation Warp Speed" to help quickly develop a Covid-19 vaccine.
Net worth over time
Principal holdings
6 positions| Company | Industry | Share | Value |
|---|---|---|---|
ImmunityBio Inc NASDAQ: IBRX | Healthcare | 46.9% | $4.4B |
Private and other holdings | Healthcare | 46.9% | $4.4B |
Bristol-Myers Squibb Co. NYSE: BMY | Healthcare | 5.5% | $512M |
RadNet Inc. NASDAQ: RDNT | Healthcare | 0.5% | $44M |
Allscripts US OTC: MDRX | Healthcare | 0.2% | $15M |
Benitec Biopharma NASDAQ: BNTC | Healthcare | 0.0% | $3M |
Also known for
- Soon-Shiong graduated from high school at age 16 and became a doctor at 23.
- Soon-Shiong was born in South Africa to Chinese immigrants.
“My quest was and is to improve the quality of life through science. That is what drove me then, and that is what is driving me now.”